JPS6416716A - Production of emulsion pharmaceutical containing sparingly soluble drug sealed therein - Google Patents
Production of emulsion pharmaceutical containing sparingly soluble drug sealed thereinInfo
- Publication number
- JPS6416716A JPS6416716A JP17294087A JP17294087A JPS6416716A JP S6416716 A JPS6416716 A JP S6416716A JP 17294087 A JP17294087 A JP 17294087A JP 17294087 A JP17294087 A JP 17294087A JP S6416716 A JPS6416716 A JP S6416716A
- Authority
- JP
- Japan
- Prior art keywords
- sparingly soluble
- phospholipid
- soluble drug
- oily ingredient
- vol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
PURPOSE:To obtain a pharmaceutical, forming a fine emulsion and capable of being parenterally, especially intraveously administered, by kneading a sparingly soluble drug with an oily ingredient in the coexistence of a phospholipid, adding an aqueous solution and emulsifying the resultant kneaded blend. CONSTITUTION:A sparingly soluble drug hardly soluble in water and oils is sufficiently kneaded and blended with an adequate amount of an oily ingredient (preferably an oil, derived from a plant and purified to a high purity) and a phospholipid to form a homogeneous dispersion system, which is then mixed with a solution prepared by dissolving the residual phospholipid in the residual oily ingredient while heating and homogenized using a homomixer. An aqueous solution containing required additives, such as emulsification adjuvant, isotonizing agent, antioxidant, dissolved therein is then added to emulsify the obtained blend and afford the aimed emulsion pharmaceutical. The above- mentioned pharmaceutical preferably consists of 0.001-30wt./vol.% sparingly soluble drug, 1-30wt./vol.%, especially 5-20wt./vol.% oily ingredient, the phospholipid in an amount of 1-50pts.wt., especially 5-35pts.wt. based on 100pts.wt. oily ingredient and water in an adequate amount.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62172940A JP2543708B2 (en) | 1987-07-13 | 1987-07-13 | Method for producing emulsion formulation encapsulating poorly soluble drug |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62172940A JP2543708B2 (en) | 1987-07-13 | 1987-07-13 | Method for producing emulsion formulation encapsulating poorly soluble drug |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6416716A true JPS6416716A (en) | 1989-01-20 |
JP2543708B2 JP2543708B2 (en) | 1996-10-16 |
Family
ID=15951168
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP62172940A Expired - Fee Related JP2543708B2 (en) | 1987-07-13 | 1987-07-13 | Method for producing emulsion formulation encapsulating poorly soluble drug |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2543708B2 (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992004886A1 (en) * | 1990-09-26 | 1992-04-02 | Meito Sangyo Co., Ltd. | Fat emulsion for intravenous injection |
WO1992007571A1 (en) * | 1990-11-06 | 1992-05-14 | Nippon Shinyaku Co., Ltd. | Process for producing fat emulsion |
US5534502A (en) * | 1990-11-06 | 1996-07-09 | Nippon Shinyaku Co. Ltd. | Process for producing fat emulsion |
US20120009250A1 (en) * | 2003-11-11 | 2012-01-12 | Claudia Mattern | Controlled release delivery system for nasal applications |
US8609043B2 (en) | 2004-12-28 | 2013-12-17 | M & P Patent Aktiengesellschaft | Use of a container of an inorganic additive containing plastic material |
US8784869B2 (en) | 2003-11-11 | 2014-07-22 | Mattern Pharma Ag | Controlled release delivery system for nasal applications and methods of treatment |
US9186320B2 (en) | 2006-10-04 | 2015-11-17 | Mattern Pharma Ag | Controlled release delivery system for nasal application of neurotransmitters |
US9757388B2 (en) | 2011-05-13 | 2017-09-12 | Acerus Pharmaceuticals Srl | Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels |
US10111888B2 (en) | 2011-05-13 | 2018-10-30 | Acerus Biopharma Inc. | Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder |
US10668084B2 (en) | 2011-05-13 | 2020-06-02 | Acerus Biopharma Inc. | Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder |
US11090312B2 (en) | 2013-03-15 | 2021-08-17 | Acerus Biopharma Inc. | Methods of treating hypogonadism with transnasal testerosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2890643B2 (en) | 1990-03-31 | 1999-05-17 | スズキ株式会社 | Outboard motor |
US20070196436A1 (en) * | 2006-02-23 | 2007-08-23 | Conopco, Inc., D/B/A Unilever | Process for preparing an edible composition comprising steroidal glycosides |
-
1987
- 1987-07-13 JP JP62172940A patent/JP2543708B2/en not_active Expired - Fee Related
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992004886A1 (en) * | 1990-09-26 | 1992-04-02 | Meito Sangyo Co., Ltd. | Fat emulsion for intravenous injection |
WO1992007571A1 (en) * | 1990-11-06 | 1992-05-14 | Nippon Shinyaku Co., Ltd. | Process for producing fat emulsion |
US5534502A (en) * | 1990-11-06 | 1996-07-09 | Nippon Shinyaku Co. Ltd. | Process for producing fat emulsion |
US8784882B2 (en) * | 2003-11-11 | 2014-07-22 | Mattern Pharma Ag | Controlled release delivery system for nasal applications and method of treatment |
US9238072B2 (en) | 2003-11-11 | 2016-01-19 | Mattern Pharma Ag | Controlled release delivery system for nasal applications and method of treatment |
US8574622B2 (en) * | 2003-11-11 | 2013-11-05 | M & P Patent Aktiengesellschaft | Controlled release delivery system for nasal applications |
US9962394B2 (en) | 2003-11-11 | 2018-05-08 | M et P Pharma AG | Controlled release delivery system for nasal applications and method of treatment |
US8784869B2 (en) | 2003-11-11 | 2014-07-22 | Mattern Pharma Ag | Controlled release delivery system for nasal applications and methods of treatment |
US20120009250A1 (en) * | 2003-11-11 | 2012-01-12 | Claudia Mattern | Controlled release delivery system for nasal applications |
US9579280B2 (en) | 2003-11-11 | 2017-02-28 | Mattern Pharma Ag | Controlled release delivery system for nasal applications and method of treatment |
US20120058176A1 (en) * | 2003-11-11 | 2012-03-08 | Claudia Mattern | Controlled release delivery system for nasal applications and method of treatment |
US8609043B2 (en) | 2004-12-28 | 2013-12-17 | M & P Patent Aktiengesellschaft | Use of a container of an inorganic additive containing plastic material |
US9186320B2 (en) | 2006-10-04 | 2015-11-17 | Mattern Pharma Ag | Controlled release delivery system for nasal application of neurotransmitters |
US9801834B2 (en) | 2006-10-04 | 2017-10-31 | M et P Pharma AG | Controlled release delivery system for nasal application of neurotransmitters |
US9757388B2 (en) | 2011-05-13 | 2017-09-12 | Acerus Pharmaceuticals Srl | Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels |
US10111888B2 (en) | 2011-05-13 | 2018-10-30 | Acerus Biopharma Inc. | Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder |
US10668084B2 (en) | 2011-05-13 | 2020-06-02 | Acerus Biopharma Inc. | Intranasal lower dosage strength testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder |
US11090312B2 (en) | 2013-03-15 | 2021-08-17 | Acerus Biopharma Inc. | Methods of treating hypogonadism with transnasal testerosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event |
US11744838B2 (en) | 2013-03-15 | 2023-09-05 | Acerus Biopharma Inc. | Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event |
Also Published As
Publication number | Publication date |
---|---|
JP2543708B2 (en) | 1996-10-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS6416716A (en) | Production of emulsion pharmaceutical containing sparingly soluble drug sealed therein | |
AU567271B2 (en) | Lyophilization of oil in water emulsion to give galenic form for oral administration | |
EP0100459B1 (en) | An aqueous liquid containing a fat-soluble substance | |
KR870002834A (en) | Manufacturing method of emulsion composition | |
CA2347118A1 (en) | Propofol composition comprising pentetate | |
JPH0336567B2 (en) | ||
JPS6025918A (en) | Aqueous solution containing fat-soluble drug | |
JPS6139924B2 (en) | ||
KR960016890A (en) | Intravenous solution of staurosporin derivative | |
JPS5793910A (en) | Preparation of emulsion for intravenous injection | |
JPS6245336A (en) | Emulsified composition | |
CN100384436C (en) | Parenteral cisplatin emulsion | |
JPS58162517A (en) | Fat-soluble vitamin-containing fatty emulsion | |
CN102370619A (en) | Fat-emulsion-emulsified local anesthetic | |
JP2779236B2 (en) | Water-dispersible lecithin | |
JPH01143826A (en) | Fat emulsion of fine particle | |
JPS58164508A (en) | Composition for external use containing isoprenyl-carboxylic acid | |
JP2000119686A (en) | Powdery oil and fat composition and preparation thereof | |
JPS6416727A (en) | Novel medical preparation of ara-c derivative | |
JPH0648939A (en) | Skin external preparation containing sodium diclofenac | |
EP0331948B1 (en) | Pharmaceutical composition for the transdermal administration of heparin | |
JPH01113315A (en) | Fat emulsion containing vitamin k2 | |
JPS57136511A (en) | Preparation of ointment base containing silicone oil with high concentration | |
JPH0399010A (en) | Pharmaceutical composition | |
JPS62175414A (en) | Emulsion cosmetic |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Cancellation because of no payment of annual fees |